The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an ...

New Jersey is breaking away from the federal Center for Disease Control's paired-down vaccine recommendations for children.

Patent infringement lawsuits claim Pfizer, BioNTech and Moderna copied technology originally developed by Monsanto.

An analysis of safety data suggests that Abrysvo, the Pfizer respiratory syncytial virus (RSV) RSVpreF vaccine, does not ...

German agrichemical giant Bayer confirmed to AFP today that it was suing American pharmaceutical firms Pfizer, Moderna and ...

A pharmacist administers the Pfizer-BioNTech Covid-19 vaccine to an attendee of an immunization event at the L.A. Care and ...

At J.P. Morgan 2026, Pfizer CEO Albert Bourla positioned the company as a post-COVID operator focused on disciplined ...

Pfizer Inc. (NYSE:PFE) is included among the 13 Best Dividend Stocks Paying Over 6%. On January 7, UBS initiated coverage of ...

Pfizer has taken a beating in recent years, and its market cap is now around $140 billion. But with the company still ...

Pfizer and BioNTech previously announced that their jointly developed COVID-19 vaccine showed over 90% effectiveness in preventing infection based on initial trial data, although scientists ...

Le géant allemand de la santé et de l'agrochimie Bayer a déclaré mercredi 7 janvier avoir porté plainte contre des fabricants ...